You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy

Article metrics

Article menu

Download PDFPDF

XML
Original research
Advanced late-onset retinitis pigmentosa with dominant-acting D477G RPE65 mutation is responsive to oral synthetic retinoid therapy

 

Online download statistics by month:

Online download statistics by month: May 2020 to March 2024

AbstractFullPdf
May 202011611046
Jun 202013212859
Jul 2020979519
Aug 2020373533
Sep 2020404012
Oct 2020463911
Nov 2020434116
Dec 2020333011
Jan 2021827846
Feb 2021292919
Mar 2021727212
Apr 2021434312
May 2021454516
Jun 202140408
Jul 202128283
Aug 2021353712
Sep 2021484819
Oct 2021434328
Nov 2021615920
Dec 2021404014
Jan 2022293315
Feb 2022434310
Mar 2022544611
Apr 2022494910
May 2022646014
Jun 2022585910
Jul 202235335
Aug 2022575512
Sep 2022474212
Oct 2022505110
Nov 2022312811
Dec 2022211910
Jan 202320197
Feb 202355518
Mar 202317173
Apr 202317167
May 2023291912
Jun 202312131
Jul 202324199
Aug 202316144
Sep 202322234
Oct 202317177
Nov 202326227
Dec 202318131
Jan 202425228
Feb 202418175
Mar 2024413867
Total20051918696